Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers
- PMID: 25400027
- DOI: 10.1002/prca.201400083
Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers
Abstract
Olfactomedin-4 (OLFM4, OLM4) is a 72 kDa secreted glycoprotein belonging to the olfactomedin family. The OLFM4 gene expression is regulated by the transcription factors NF-kappa B and AP-1, and the OLM4 functions are poorly understood. OLM4 has been described as being able to interact with cell surface proteins such as lectins and concanavalin-A suggesting that one function of OLM4 is to regulate cell adhesion and migration. OLM4 is a marker for intestinal stem cells and is expressed at the bottom of the intestinal crypts. Expression of OLM4 during tumor development showed that OLM4 expression is increased in the early stages of tumor initiation. As OLM4 is a secreted protein, it is a prime candidate for biomarker research for tumor detection or progression. Levels of circulating OLM4 were significantly higher in patients with gastric, colorectal, and pancreatic cancers than in healthy subjects.
Keywords: Biomarker; Cancer; OLFM4; Olfactomedin 4.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer.J Pathol Clin Res. 2023 Jan;9(1):73-85. doi: 10.1002/cjp2.300. Epub 2022 Nov 8. J Pathol Clin Res. 2023. PMID: 36349502 Free PMC article.
-
Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.Cancer Metastasis Rev. 2016 Jun;35(2):201-12. doi: 10.1007/s10555-016-9624-2. Cancer Metastasis Rev. 2016. PMID: 27178440 Review.
-
Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.Int J Cancer. 2020 Mar 1;146(5):1346-1358. doi: 10.1002/ijc.32535. Epub 2019 Jul 9. Int J Cancer. 2020. PMID: 31241767 Free PMC article.
-
Olfactomedin-4 in digestive diseases: A mini-review.World J Gastroenterol. 2018 May 7;24(17):1881-1887. doi: 10.3748/wjg.v24.i17.1881. World J Gastroenterol. 2018. PMID: 29740203 Free PMC article. Review.
-
Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway.Sci Rep. 2015 Nov 19;5:16974. doi: 10.1038/srep16974. Sci Rep. 2015. PMID: 26581960 Free PMC article.
Cited by
-
Research status and progress of the RNA or protein biomarkers for prostate cancer.Onco Targets Ther. 2019 Mar 22;12:2123-2136. doi: 10.2147/OTT.S194138. eCollection 2019. Onco Targets Ther. 2019. PMID: 30962694 Free PMC article. Review.
-
Dysregulation of iron transport-related biomarkers in blood leukocytes is associated with poor prognosis of early trauma.Heliyon. 2024 Feb 28;10(5):e27000. doi: 10.1016/j.heliyon.2024.e27000. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38463887 Free PMC article.
-
Matricellular proteins in cutaneous wound healing.Front Cell Dev Biol. 2022 Nov 24;10:1073320. doi: 10.3389/fcell.2022.1073320. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36506087 Free PMC article. Review.
-
Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.Cancers (Basel). 2022 Aug 13;14(16):3921. doi: 10.3390/cancers14163921. Cancers (Basel). 2022. PMID: 36010914 Free PMC article. Review.
-
Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer.J Pathol Clin Res. 2023 Jan;9(1):73-85. doi: 10.1002/cjp2.300. Epub 2022 Nov 8. J Pathol Clin Res. 2023. PMID: 36349502 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous